Cargando…

T-cell Metabolism as a Target to Control Autoreactive T Cells in β-Cell Autoimmunity

PURPOSE OF REVIEW: An increasing body of evidence indicates that bio-energetic metabolism of activated T cells is a potential target to control the autoimmune response in type 1 diabetes (T1D). RECENT FINDINGS: T-cell activation and proliferation is linked to the cell capacity to provide sufficient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bordignon, Carlotta, Canu, Adriana, Dyczko, Aleksandra, Leone, Serena, Monti, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Immunology, Transplantation, and Regenerative Medicine (L Piemonti and V Sordi, Section Editors)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355511/ https://www.ncbi.nlm.nih.gov/pubmed/28303386 http://dx.doi.org/10.1007/s11892-017-0848-5

Ejemplares similares

Targeting Homeostatic T Cell Proliferation to Control Beta-Cell Autoimmunity
por: Vignali, Debora, et al.
Publicado: (2016)

Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic Complications
por: Mangialardi, Giuseppe, et al.
Publicado: (2016)

Biomarkers in Islet Cell Transplantation for Type 1 Diabetes
por: AlRashidi, Fatimah T., et al.
Publicado: (2018)

GPR44 as a Target for Imaging Pancreatic Beta-Cell Mass
por: Eriksson, Olof
Publicado: (2019)

Heterogeneity in the Beta-Cell Population: a Guided Search Into Its Significance in Pancreas and in Implants
por: Pipeleers, Daniel, et al.
Publicado: (2017)

Artificial Pancreas or Novel Beta-Cell Replacement Therapies: a Race for Optimal Glycemic Control?
por: Nijhoff, Michiel F., et al.
Publicado: (2018)

Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy
por: Gu, Y., et al.
Publicado: (2021)

Pancreas-on-a-Chip Technology for Transplantation Applications
por: Abadpour, Shadab, et al.
Publicado: (2020)

Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis
por: McLaughlin, Rene J., et al.
Publicado: (2016)

Simultaneous Pancreas-Kidney Transplantation Versus Living Donor Kidney Transplantation Alone: an Outcome-Driven Choice?
por: Venkatanarasimhamoorthy, Vishnu Swaroop, et al.
Publicado: (2018)

Therapeutic Strategies for Modulating the Extracellular Matrix to Improve Pancreatic Islet Function and Survival After Transplantation
por: Smink, Alexandra M., et al.
Publicado: (2018)

Machine Perfusion and the Pancreas: Will It Increase the Donor Pool?
por: Hamaoui, Karim, et al.
Publicado: (2019)

Who Should Be Considered for Islet Transplantation Alone?
por: Othonos, Nantia, et al.
Publicado: (2017)

Immunomodulatory Properties of Amniotic Membrane Derivatives and Their Potential in Regenerative Medicine
por: Wassmer, Charles-Henri, et al.
Publicado: (2020)

Updates on Gene Therapy for Diabetic Retinopathy
por: Wang, Jiang-Hui, et al.
Publicado: (2020)

Organoids from the Human Fetal and Adult Pancreas
por: Balak, Jeetindra R. A., et al.
Publicado: (2019)

Pancreas Transplantation from Donors after Circulatory Death: an Irrational Reluctance?
por: Leemkuil, M., et al.
Publicado: (2019)

Superoxide Production by Macrophages and T Cells Is Critical for the Induction of Autoreactivity and Type 1 Diabetes
por: Thayer, Terri C., et al.
Publicado: (2011)

Human β-Cell Killing by Autoreactive Preproinsulin-Specific CD8 T Cells Is Predominantly Granule-Mediated With the Potency Dependent Upon T-Cell Receptor Avidity
por: Knight, Robin R., et al.
Publicado: (2013)

Simultaneous Detection of Circulating Autoreactive CD8(+) T-Cells Specific for Different Islet Cell–Associated Epitopes Using Combinatorial MHC Multimers
por: Velthuis, Jurjen H., et al.
Publicado: (2010)

NK Cell Autoreactivity and Autoimmune Diseases
por: Poggi, Alessandro, et al.
Publicado: (2014)

Induction of Mixed Chimerism With MHC-Mismatched but Not Matched Bone Marrow Transplants Results in Thymic Deletion of Host-Type Autoreactive T-Cells in NOD Mice
por: Racine, Jeremy, et al.
Publicado: (2011)

T-Cell Promiscuity in Autoimmune Diabetes
por: Li, Li, et al.
Publicado: (2008)

MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity
por: Tsai, Sue, et al.
Publicado: (2013)

Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes
por: Fiorina, Paolo, et al.
Publicado: (2008)

Prevention of Autoimmune Diabetes by Ectopic Pancreatic β-Cell Expression of Interleukin-35
por: Bettini, Maria, et al.
Publicado: (2012)

Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of Autoimmunity
por: Solé, Patricia, et al.
Publicado: (2021)

Prevention of Autoimmune Diabetes and Induction of β-Cell Proliferation in NOD Mice by Hyperbaric Oxygen Therapy
por: Faleo, Gaetano, et al.
Publicado: (2012)

Inotuzumab Ozogamicin Murine Analog–Mediated B-Cell Depletion Reduces Anti-islet Allo- and Autoimmune Responses
por: Carvello, Michele, et al.
Publicado: (2012)

Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death
por: Arif, Sefina, et al.
Publicado: (2011)

Expansion of Th17 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 Diabetes
por: Ferraro, Alessandra, et al.
Publicado: (2011)

CD28/CD154 Blockade Prevents Autoimmune Diabetes by Inducing Nondeletional Tolerance After Effector T-Cell Inhibition and Regulatory T-Cell Expansion
por: Rigby, Mark R., et al.
Publicado: (2008)

Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4(+)CD25(+)FOXP3(+) Regulatory T-Cells
por: Monti, Paolo, et al.
Publicado: (2008)

Immune Cell–Derived C3 Is Required for Autoimmune Diabetes Induced by Multiple Low Doses of Streptozotocin
por: Lin, Marvin, et al.
Publicado: (2010)

Immune Regulatory Properties of Allogeneic Adipose-Derived Mesenchymal Stem Cells in the Treatment of Experimental Autoimmune Diabetes
por: Bassi, Ênio J., et al.
Publicado: (2012)

Anti-Islet Autoantibodies Trigger Autoimmune Diabetes in the Presence of an Increased Frequency of Islet-Reactive CD4 T Cells
por: Silva, Diego G., et al.
Publicado: (2011)

Mechanisms Underlying Antigen-Specific Tolerance of Stable and Convertible Th17 Cells During Suppression of Autoimmune Diabetes
por: Wan, Xiaoxiao, et al.
Publicado: (2012)

Identification of Autoreactive B Cell Subpopulations in Peripheral Blood of Autoimmune Patients With Pemphigus Vulgaris
por: Pollmann, Robert, et al.
Publicado: (2019)

Slc11a1 Enhances the Autoimmune Diabetogenic T-Cell Response by Altering Processing and Presentation of Pancreatic Islet Antigens
por: Dai, Yang D., et al.
Publicado: (2009)

Transforming Growth Factor-β Suppresses the Activation of CD8(+) T-Cells When Naïve but Promotes Their Survival and Function Once Antigen Experienced : A Two-Faced Impact on Autoimmunity
por: Filippi, Christophe M., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_1cqe0fjtvapev15r91ns6ufdcc